Category: News Release

IDEX Health & Science (IH&S) recently announced it has reached a major milestone, shipping its 5 millionth Semrock optical filter. IH&S design and process control of Semrock optical filters provides the life science market with an important and robust component that has become widely accepted as the industry standard. More recently, Semrock optical filters have played a role in detecting (through PCR instruments) and monitoring (through sequencing instruments) the SARS-CoV-2 virus that causes COVID-19 resulting in a significant increase in demand.

Used to discriminate wavelengths of light, Semrock optical filters drive sensitivity of detection of fluorescent-labeled molecules. In life science applications like super-resolution microscopy, DNA sequencing, and hyperspectral imaging, the instrument interrogates the sample on a photon by photon basis and depends on the Semrock optical filter to precisely block or pass specific wavelengths of light. This is achieved by highly controlled molecular deposition methods and integrated design algorithms.

Founded in 2000, Semrock Inc. became a unit of IDEX Health & Science in 2015. The Semrock filter line is manufactured in the IH&S state-of-the-art facility in Rochester, New York. This manufacturing, research, and development center of excellence enables scalable growth for IDEX Health & Science’s optical components, sub-systems, and filters business lines. All Semrock optical filters are made with hard-coated sputtered thin-film coatings. Patented products include the BrightLine^® fluorescence filters, RazorEdge^® Raman spectroscopy filters, StopLine^® notch filters, VersaChrome^® tunable filters, Polarization bandpass filters, and PulseLine™ femtosecond optics.

“Supplying 5 million optical filters is a great achievement for our organization” said Joe Rytell, President of IDEX Health & Science. “But what’s most impressive is the role IH&S has played in supporting our customers whose instruments are being used 24/7 in the fight against this pandemic. I could not be more proud of our employees as they deliver on our mission and take care of each other during these extraordinary times. IH&S gives thanks to all its customers and key suppliers for helping to make this remarkable milestone possible during these challenging times.”

 

About IDEX Health & Science, LLC

IDEX Health & Science, LLC is the global leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, solutions, and expertise. As one of the few companies in the world with component, sub-system, and application level experts, IDEX Health & Science helps instrument developers solve the most demanding fluidic and optical challenges in a wide array of applications. At IDEX Health & Science we believe partnership will change the way the world innovates, leading to new technologies that improve our health, protect our planet, and enrich our lives. For more information visit: www.idex-hs.com  and at www.Semrock.com

IDEX Corporation (NYSE:IEX) today completed its previously announced acquisition of Flow Management Devices, LLC (Flow MD), a privately-held provider of flow measurement systems that ensure custody transfer accuracy in the oil and gas industry.

“Adding Flow MD to the IDEX family of businesses extends our expertise in the energy sector, where we already serve refineries, chemical manufacturers and pipeline operators,” IDEX Chairman and CEO Andy Silvernail said. “We welcome all Flow MD employees and customers to IDEX. We look forward to fully integrating the company into our unique values-based culture and operating model.”

Flow MD joins IDEX’s energy group, complementing the pump and metering systems produced by fellow IDEX companies SAMPI, Toptech Systems, Liquid Controls and Corken. Flow MD products are known for their accuracy, repeatability, and reliability, with technology that is liquid and meter agnostic. In addition to its headquarters and manufacturing facilities in Phoenix, Flow MD has offices in Houston and Pittsburgh.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200228005541/en/

The IDEX Corporation (NYSE:IEX) Board of Directors voted February 21 to award Chief Operating Officer (COO) Eric Ashleman the additional title of President. The title had been held by Chairman and Chief Executive Officer Andy Silvernail, who retains those two positions.

The addition of the title President reflects Ashleman’s continued development as a senior leader and the impact he has on the organization. Ashleman has been COO for five years, during which time he has been an integral part of the IDEX’s success, including his role in developing the company’s distinct culture, business model and strategy. This decision is part of the Board of Director’s disciplined approach to long-term executive development and succession planning.

“Eric’s leadership and vision have been instrumental to the success of our company. He has been on the forefront of our unique approach to building an extraordinary enterprise that delivers excellence for our customers, shareholders, team, and community,” Silvernail said.

Ashleman and Silvernail have worked together at IDEX for more than a decade and IDEX has thrived under their partnership, posting significant growth in sales, margin, earnings, and return on capital. Since Ashleman became COO in July 2015, Total Shareholder Return for IDEX has increased 138 percent, more than double the return for the S&P 500 over that same period of time.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005920/en/

 

About IDEX

IDEX is a global fluidics leader serving high growth specialized markets. We are best known for our expertise in highly engineered fluidics systems and components, as well as for our expertise in fire and safety products including the Jaws of Life® family of rescue and recovery tools. Our products touch lives every day. Whether it’s a life-saving rescue operation, dispensing fresh juice to a first grader or fueling aircraft, IDEX is a leader in creating enabling technology used in many of the most common everyday activities. For more information, please visit www.idexcorp.com. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX.”

 

IDEX Corporation (NYSE:IEX) today announced that it has entered into a definitive agreement to acquire Flow Management Devices, LLC (Flow MD), a privately-held provider of flow measurement systems that ensure custody transfer accuracy in the oil and gas industry, for cash consideration of $125 million, before closing adjustments.

Flow MD engineers and manufactures technically-differentiated “unidirectional captive displacement provers,” also called “small volume provers.” In a market where slight inaccuracies in flow meter measurements at transfer points can result in enormous payment discrepancies for customers, Flow MD’s calibration products serve a critical application.

Flow MD has annual sales of approximately $60 million, and will join IDEX’s energy group, complementing the pump and metering systems produced by fellow IDEX companies SAMPI, Toptech Systems, Liquid Controls and Corken.

“Adding Flow MD to the IDEX family of businesses will extend our expertise in providing highly-engineered solutions to energy customers, including refineries, chemical manufacturers and pipeline operators,” IDEX Chairman and CEO Andy Silvernail said. “In our unique structure, companies retain a great deal of autonomy, while benefitting from the expertise and operating model at IDEX. Flow MD should flourish as part of our culture, where great teams win together by focusing on the things that matter most, combined with an obsession for solving our customers’ most challenging problems.”

To read the full announcement, click here

 

 

IDEX Corporation (NYSE:IEX) today announced the acquisition of Velcora Holding AB and its Roplan and Steridose businesses from FSN Capital Partners for cash consideration of 1.28 billion Swedish kronor (~$137 million).

Roplan is a global manufacturer of custom mechanical and shaft seals for a variety of end markets including food & beverage, marine, chemical, wastewater and water treatment. Steridose develops engineered hygienic mixers and valves for the global biopharmaceutical industry. Both companies are headquartered in Sweden, with operations in China, the United Kingdom and the United States. Total revenues are approximately 375 million Swedish kronor (~$40 million).

“We welcome Roplan and Steridose to the IDEX family of businesses. These companies complement both our Sealing Solutions as well as Health and Sciences platforms well,” IDEX Chairman and CEO Andy Silvernail said. “In our unique structure, companies retain a great deal of autonomy, while benefitting from the expertise and operating model at IDEX. Roplan and Steridose should flourish as part of our culture, where great teams win together by focusing on the things that matter most, combined with an obsession on solving our customers’ most challenging problems.”

To view source version on businesswire.com: https://www.businesswire.com/news/home/20190718005337/en/